Mida Pezeshkian, PhD is a seasoned product and strategy leader with over a decade of experience across genomics, clinical diagnostics laboratory, and digital health/AI. With an interdisciplinary scientific training and a wide ranging professional experience in highly complex and regulated industries, Mida brings a unique perspective and valuable expertise to solve critical business problems. Over the course of her professional career, Mida has developed and commercialized several cutting-edge life sciences tools and digital health products, creating significant value for shareholders and investors.

Mida completed her BS in Biochemistry from West Chester University of Pennsylvania. She holds a PhD in Biological and Biomedical Sciences from Oakland University, where she published and patented a novel biosensor to detect disease stage and relapse in acute myeloid leukemia (AML). She then completed her postdoctoral training at University of Michigan Medical School. Mida is a CHIEF member and serves as board member and advisor to multiple academic and start-up organizations.